In 2011, Rahul Singhvi earned $1.22M in total compensation at Novavax, primarily from $454.55K salary. Led Novavax as CEO for 6 years.
Compensation History
Annual executive compensation data for Rahul Singhvi, including salary, bonuses, and stock awards.
Year
2011
Total Compensation
$1.22M
Salary
$454.55K
Bonus
$0.00
Other
$761.49K
Salary
$454.55KBoard Justification
The compensation philosophy is designed to attract, retain, and reward a performing workforce in a competitive market, aligning compensation with company performance and individual contributions.
Bonus
$0.00Board Justification
No bonus was awarded as Dr. Singhvi's employment ended on April 19, 2011.
Other Compensation
$761.49KBoard Justification
This includes severance payments and accrued vacation pay upon termination of employment.
Restricted Stock
Board Justification
No stock awards vested in 2011 as Dr. Singhvi's employment ended before any awards could vest.
Performance Metrics
The performance metrics for Dr. Singhvi's compensation were based on the achievement of corporate objectives and individual performance evaluations.
Rahul Singhvi
Ex-CEO of Novavax
Sector of Economy
Healthcare
CEO of Novavax for
6 years 0 months (Apr 2005 - Apr 2011)
Previous Experience
Unknown
Other Novavax CEOs
Holdings
Track Rahul Singhvi's stock holdings and portfolio value over time.
Insider Trading
Rahul Singhvi's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Rahul Singhvi with competitor CEOs and industry peers.
Albert Bourla
CEO of Pfizer
2024 Compensation
Stock
$0.00
Salary
$1.80M
Bonus
$7.02M
Other
$996.06K
Total Holdings
$18.14M
Joaquin Duato
CEO of Johnson & Johnson
2024 Compensation
Stock
$7.13M
Salary
$1.60M
Bonus
$3.22M
Other
$1.08M
Total Holdings
$1.09M
Stéphane Bancel
CEO of Moderna
2023 Compensation
Stock
$0.00
Salary
$1.58M
Bonus
$1.91M
Other
$1.07M
Total Holdings
$335.71M